OR52I2 inhibitors represent a specialized class of chemical compounds that interact with the olfactory receptor OR52I2, a G-protein coupled receptor (GPCR) primarily expressed in the olfactory epithelium. These inhibitors function by modulating the activity of OR52I2, which plays a crucial role in the detection of odor molecules and the initiation of olfactory signal transduction. GPCRs like OR52I2 are part of a large and diverse family of proteins that mediate responses to external stimuli, such as light, hormones, and odorants, through a mechanism involving the activation of intracellular signaling cascades. OR52I2 is highly selective for specific odorants, and inhibitors of this receptor block the binding or signal transmission that would otherwise occur in the presence of such odorants.
The structural features of OR52I2 inhibitors often involve molecular moieties designed to fit into the receptor's binding pocket, preventing the conformational changes required for signal transduction. These compounds typically contain hydrophobic, aromatic, or heterocyclic groups that align with the receptor's ligand-binding domains. The study of OR52I2 inhibitors extends into the broader understanding of olfactory receptor function, as modulating these receptors allows for the investigation of sensory perception at the molecular level. Additionally, the selective inhibition of OR52I2 can serve as a tool for studying GPCR signal pathways, helping to reveal more about receptor-ligand interactions, protein conformational dynamics, and cellular response mechanisms related to the sense of smell. This field is integral to understanding how specific molecules influence olfactory function, providing valuable insights into receptor biochemistry and signal transduction networks.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This nucleoside analog could demethylate cytosines within the OR52I2 gene promoter, potentially downregulating its transcription. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
By inhibiting histone deacetylase activity, this compound may lead to hyperacetylation of histone proteins associated with the OR52I2 gene, resulting in the downregulation of its expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
This dactinomycin could intercalate between guanine and cytosine bases of DNA, thereby obstructing the elongation phase of RNA polymerase during OR52I2 gene transcription, effectively reducing its expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Known to bind to DNA at GC-rich sequences, this antineoplastic antibiotic could disrupt transcription factor access to the OR52I2 promoter, decreasing gene expression. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
This non-nucleoside DNA methyltransferase inhibitor may specifically target and inhibit the methylation of the OR52I2 promoter, leading to its downregulated expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Functioning similarly to 5-Azacytidine, this compound might selectively incorporate into DNA and reduce the methylation status of the OR52I2 gene promoter, thereby inhibiting gene expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
As a short-chain fatty acid, it could inhibit histone deacetylases, increasing acetylation near the OR52I2 locus and consequently decreasing its transcriptional activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This catechin, abundant in green tea, may inhibit DNA methyltransferases, leading to a potential reduction in methylation of the OR52I2 gene promoter, inhibiting its expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Approved as an HDAC inhibitor, vorinostat may cause increased acetylation of histones at the OR52I2 gene locus, which could lead to the chromatin remodeling necessary for downregulating its expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
This metabolite of vitamin A could bind to retinoic acid receptors and alter the transcription of genes, including OR52I2, potentially resulting in decreased expression levels. | ||||||